216 related articles for article (PubMed ID: 33202000)
21. Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum.
Naguib FNM; Wilson CM; El Kouni MH
Int J Biochem Cell Biol; 2018 Dec; 105():115-122. PubMed ID: 30381242
[TBL] [Abstract][Full Text] [Related]
22. New insights into host-parasite ubiquitin proteome dynamics in P. falciparum infected red blood cells using a TUBEs-MS approach.
Mata-Cantero L; Azkargorta M; Aillet F; Xolalpa W; LaFuente MJ; Elortza F; Carvalho AS; Martin-Plaza J; Matthiesen R; Rodriguez MS
J Proteomics; 2016 Apr; 139():45-59. PubMed ID: 26972027
[TBL] [Abstract][Full Text] [Related]
23. The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.
Looker O; Dans MG; Bullen HE; Sleebs BE; Crabb BS; Gilson PR
Traffic; 2022 Sep; 23(9):442-461. PubMed ID: 36040075
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251.
Morita M; Sanai H; Hiramoto A; Sato A; Hiraoka O; Sakura T; Kaneko O; Masuyama A; Nojima M; Wataya Y; Kim HS
J Proteome Res; 2012 Dec; 11(12):5704-11. PubMed ID: 23061985
[TBL] [Abstract][Full Text] [Related]
25. Protein-drug interaction studies for development of drugs against Plasmodium falciparum.
de Azevedo WF; Caceres RA; Pauli I; Timmers LF; Barcellos GB; Rocha KB; Soares MB
Curr Drug Targets; 2009 Mar; 10(3):271-8. PubMed ID: 19275563
[TBL] [Abstract][Full Text] [Related]
26. Partial characterization of Plasmodium falciparum trophozoite proteome under treatment with quinine, mefloquine and the natural antiplasmodial diosgenone.
Segura C; Cuesta-Astroz Y; Nunes-Batista C; Zalis M; von Krüger WM; Mascarello Bisch P
Biomedica; 2014; 34(2):237-49. PubMed ID: 24967929
[TBL] [Abstract][Full Text] [Related]
27. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
Tuteja R
FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
[TBL] [Abstract][Full Text] [Related]
28. Exploiting the therapeutic potential of Plasmodium falciparum solute transporters.
Staines HM; Derbyshire ET; Slavic K; Tattersall A; Vial H; Krishna S
Trends Parasitol; 2010 Jun; 26(6):284-96. PubMed ID: 20392668
[TBL] [Abstract][Full Text] [Related]
29. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
Chhibber-Goel J; Yogavel M; Sharma A
Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
[TBL] [Abstract][Full Text] [Related]
32. Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against
Birrell GW; Challis MP; De Paoli A; Anderson D; Devine SM; Heffernan GD; Jacobus DP; Edstein MD; Siddiqui G; Creek DJ
Mol Cell Proteomics; 2020 Feb; 19(2):308-325. PubMed ID: 31836637
[TBL] [Abstract][Full Text] [Related]
33. Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin.
Chen L; Zheng Z; Liu H; Wang X; Qu S; Yang Y; Deng S; Zhang Y; Tuo L; Zhao Y; Li Y
Microbiol Spectr; 2021 Dec; 9(3):e0127821. PubMed ID: 34908430
[TBL] [Abstract][Full Text] [Related]
34. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
Famin O; Ginsburg H
Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
[TBL] [Abstract][Full Text] [Related]
35. Plasmodium kinases as targets for new-generation antimalarials.
Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
[TBL] [Abstract][Full Text] [Related]
36. Protein Kinase A Is Essential for Invasion of Plasmodium falciparum into Human Erythrocytes.
Wilde ML; Triglia T; Marapana D; Thompson JK; Kouzmitchev AA; Bullen HE; Gilson PR; Cowman AF; Tonkin CJ
mBio; 2019 Oct; 10(5):. PubMed ID: 31594816
[TBL] [Abstract][Full Text] [Related]
37. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium falciparum heat shock proteins as antimalarial drug targets: An update.
Ahmad T; Alhammadi BA; Almaazmi SY; Arafa S; Blatch GL; Dutta T; Gestwicki JE; Keyzers RA; Shonhai A; Singh H
Cell Stress Chaperones; 2024 Apr; 29(2):326-337. PubMed ID: 38518861
[TBL] [Abstract][Full Text] [Related]
39. Parasite and Host Erythrocyte Kinomics of Plasmodium Infection.
Adderley J; Williamson T; Doerig C
Trends Parasitol; 2021 Jun; 37(6):508-524. PubMed ID: 33593681
[TBL] [Abstract][Full Text] [Related]
40. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
Qidwai T
Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
